Format

Send to

Choose Destination
ISME J. 2014 Jul;8(7):1403-17. doi: 10.1038/ismej.2014.3. Epub 2014 Feb 6.

Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission.

Author information

1
Harvard School of Public Health, Boston, MA, USA.
2
1] Harvard School of Public Health, Boston, MA, USA [2] Danone Research, Palaiseau, France.
3
1] Harvard School of Public Health, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.
4
Danone Research, Palaiseau, France.
5
Children's Hospital, Boston, MA, USA.
6
Harvard Medical School, Boston, MA, USA.
7
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
8
1] Harvard School of Public Health, Boston, MA, USA [2] Broad Institute of Harvard and MIT, Cambridge, MA, USA.
9
1] Harvard School of Public Health, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Broad Institute of Harvard and MIT, Cambridge, MA, USA [4] Dana-Farber Cancer Institute, Boston, MA, USA.

Abstract

Dysregulated immune responses to gut microbes are central to inflammatory bowel disease (IBD), and gut microbial activity can fuel chronic inflammation. Examining how IBD-directed therapies influence gut microbiomes may identify microbial community features integral to mitigating disease and maintaining health. However, IBD patients often receive multiple treatments during disease flares, confounding such analyses. Preclinical models of IBD with well-defined disease courses and opportunities for controlled treatment exposures provide a valuable solution. Here, we surveyed the gut microbiome of the T-bet(-/-) Rag2(-/-) mouse model of colitis during active disease and treatment-induced remission. Microbial features modified among these conditions included altered potential for carbohydrate and energy metabolism and bacterial pathogenesis, specifically cell motility and signal transduction pathways. We also observed an increased capacity for xenobiotics metabolism, including benzoate degradation, a pathway linking host adrenergic stress with enhanced bacterial virulence, and found decreased levels of fecal dopamine in active colitis. When transferred to gnotobiotic mice, gut microbiomes from mice with active disease versus treatment-induced remission elicited varying degrees of colitis. Thus, our study provides insight into specific microbial clades and pathways associated with health, active disease and treatment interventions in a mouse model of colitis.

PMID:
24500617
PMCID:
PMC4069400
DOI:
10.1038/ismej.2014.3
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center